BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22230565)

  • 1. Engineering cyclic peptide toxins.
    Clark RJ; Craik DJ
    Methods Enzymol; 2012; 503():57-74. PubMed ID: 22230565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native chemical ligation applied to the synthesis and bioengineering of circular peptides and proteins.
    Clark RJ; Craik DJ
    Biopolymers; 2010; 94(4):414-22. PubMed ID: 20593458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of cyclic disulfide-rich peptides.
    Akcan M; Craik DJ
    Methods Mol Biol; 2013; 1047():89-101. PubMed ID: 23943480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering of conotoxins for the treatment of pain.
    Carstens BB; Clark RJ; Daly NL; Harvey PJ; Kaas Q; Craik DJ
    Curr Pharm Des; 2011 Dec; 17(38):4242-53. PubMed ID: 22204425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies of conotoxins.
    Daly NL; Craik DJ
    IUBMB Life; 2009 Feb; 61(2):144-50. PubMed ID: 19165896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclization of conotoxins to improve their biopharmaceutical properties.
    Clark RJ; Akcan M; Kaas Q; Daly NL; Craik DJ
    Toxicon; 2012 Mar; 59(4):446-55. PubMed ID: 21147143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII.
    Clark RJ; Fischer H; Dempster L; Daly NL; Rosengren KJ; Nevin ST; Meunier FA; Adams DJ; Craik DJ
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13767-72. PubMed ID: 16162671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of conotoxins to improve stability and activity.
    Craik DJ; Adams DJ
    ACS Chem Biol; 2007 Jul; 2(7):457-68. PubMed ID: 17649970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Solid phase peptide synthesis: interest in the valorization of molecular substances from animal venoms].
    Aidi-Knani S; Ghodhbane H; Mourre Ch; Benhamida J; Jean-Marc S; Regaya I
    Arch Inst Pasteur Tunis; 2014; 91(1-4):33-41. PubMed ID: 26402968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Engineering of Conus Peptides as Therapeutic Leads.
    Daniel JT; Clark RJ
    Adv Exp Med Biol; 2017; 1030():229-254. PubMed ID: 29081056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of conopeptides.
    Schroeder CI; Craik DJ
    Future Med Chem; 2012 Jun; 4(10):1243-55. PubMed ID: 22800369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemical synthesis of α-conotoxins and structurally modified analogs with enhanced biological stability.
    Banerjee J; Gyanda R; Chang YP; Armishaw CJ
    Methods Mol Biol; 2013; 1081():13-34. PubMed ID: 24014431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fmoc-based synthesis of disulfide-rich cyclic peptides.
    Cheneval O; Schroeder CI; Durek T; Walsh P; Huang YH; Liras S; Price DA; Craik DJ
    J Org Chem; 2014 Jun; 79(12):5538-44. PubMed ID: 24918986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel conotoxin framework with a helix-loop-helix (Cs alpha/alpha) fold.
    Möller C; Rahmankhah S; Lauer-Fields J; Bubis J; Fields GB; Marí F
    Biochemistry; 2005 Dec; 44(49):15986-96. PubMed ID: 16331958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
    Blanchfield JT; Dutton JL; Hogg RC; Gallagher OP; Craik DJ; Jones A; Adams DJ; Lewis RJ; Alewood PF; Toth I
    J Med Chem; 2003 Mar; 46(7):1266-72. PubMed ID: 12646037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel class of conotoxins defined as V-conotoxins with a unique cysteine pattern and signal peptide sequence.
    Peng C; Liu L; Shao X; Chi C; Wang C
    Peptides; 2008 Jun; 29(6):985-91. PubMed ID: 18304695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA display selection and solid-phase synthesis of Fc-binding cyclic peptide affinity ligands.
    Menegatti S; Hussain M; Naik AD; Carbonell RG; Rao BM
    Biotechnol Bioeng; 2013 Mar; 110(3):857-70. PubMed ID: 23108907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic MrIA: a stable and potent cyclic conotoxin with a novel topological fold that targets the norepinephrine transporter.
    Lovelace ES; Armishaw CJ; Colgrave ML; Wahlstrom ME; Alewood PF; Daly NL; Craik DJ
    J Med Chem; 2006 Nov; 49(22):6561-8. PubMed ID: 17064074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor.
    Halai R; Callaghan B; Daly NL; Clark RJ; Adams DJ; Craik DJ
    J Med Chem; 2011 Oct; 54(19):6984-92. PubMed ID: 21888386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel alpha-conotoxins identified by gene sequencing from cone snails native to Hainan, and their sequence diversity.
    Luo S; Zhangsun D; Zhang B; Quan Y; Wu Y
    J Pept Sci; 2006 Nov; 12(11):693-704. PubMed ID: 16981242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.